Industry News
The latest medical device regulatory news, clinical trials, and market insights
Mergers and Acquisitions Alert: Investigating VTYX, ALEX, RVYL, and FFWM Deals
Monteverde & Associates PC, a national class action securities firm, is investigating the mergers of VTYX, ALEX, RVYL, and FFWM.…
New Mexico Law Triggers Review of Two Health Care Mergers Since 2024
New Mexico has triggered the review of two health care mergers since 2024 under a new law aimed at increasing…
Mercury Pharmaceuticals Ltd Issues Precautionary Recall of Paliperidone Pre-Filled Syringes Due to GMP Deficiencies
Published on 2026-01-26T18:30:14.000Z, a significant recall alert has been issued by Mercury Pharmaceuticals Ltd. The company is recalling the remaining…
PraxisPro Secures $6M in Seed Funding from AlleyCorp to Revolutionize Medical Sales Training
PraxisPro, a startup focused on coaching medical sales representatives, has raised $6 million in seed funding from AlleyCorp, a prominent…
Glenmark Pharmaceuticals Europe Limited Issues Precautionary Recall of Fingolimod Glenmark 0.5 mg Hard Capsules
Meta description: Glenmark Pharmaceuticals Europe Limited recalls Fingolimod Glenmark 0.5 mg Hard Capsules due to stability testing issues. Published on…
Federal Court Blocks Merger of Two Companies Developing Life-Saving Heart Device
A federal court has blocked the merger of two companies, Edwards Lifesciences and JenaValve Technology, that are developing a life-saving…
Medical Device Field Safety Notices Issued from 12 to 16 January 2026
As of 22 January 2026, a series of field safety notices were issued for medical devices used in various clinical…
Olympus Expands Recall of ViziShot 2 FLEX Needles Over Patient Safety Concerns
January 17, 2026 OLYMPUS CORPORATION has expanded its global medical device removal action for ViziShot 2 FLEX (19G) EBUS-TBNA needles,…
Swissmedic Expands Indication for Amvuttra
Published January 26, 2026 The Swiss Agency for Therapeutic Products (Swissmedic) announced an extension of the therapeutic indication for Amvuttra,…
Swissmedic Introduces New Requirements for Integral Combination Products
On January 21, 2026, Swissmedic announced new requirements for the authorization of medicinal products with integral medical device components, also…
Swissmedic Batch Recall of Risperidon-Mepha LA Injection
What Changed? As of January 22, 2026, Swissmedic announced a batch recall of Risperidon-Mepha LA Pulver und Lösungsmittel zur Herstellung…
